Table 3 End-point values after the 6-week intervention period with either the control drink (Control) or the drink containing rose hip (Rose hip)

From: Effects of rose hip intake on risk markers of type 2 diabetes and cardiovascular disease: a randomized, double-blind, cross-over investigation in obese persons

 

Control

Rose hip

P

Body weight (kg)

101.9±2.91

102.7±3.1

NS

BMI (kg/m2)

36.6±1.0

35.9±0.9

NS

FP-glucose (mmol/l)

5.6±0.2

5.7±0.2

NS

FP-insulin (mIU/l)

12.5±0.9

12.5±0.9

NS

HbA1c (mmol/mol)

35±0.4

35±0.6

NS

TG (mmol/l)

1.5±0.1

1.5±0.1

NS

P-ASAT (μkat/l)

0.48±0.06

0.43±0.03

NS

P-ALAT (μkat/l)

0.49±0.07

0.54±0.06

NS

P-GT (μkat/l)

0.49±0.07

0.48±0.05

NS

P-ALP (μkat/l)

1.1±0.05

1.2±0.05

NS

P-bilirubin (μmol/l)

7.8±0.5

7.9±0.5

NS

CRP (mg/l)

3.7±3.01

3.8±3.6

NS

Adiponectin (mg/l)

16.4±1.7

14.9±1.5

NS

PAI-1 (IU/ml)

27.6±3.2

29.9±3.4

NS

  1. Abbreviations: BMI, body mass index; CRP, C-reactive protein; FP, fasting plasma; P-ALAT, plasma-alanine aminotransferase; P-ALP, plasma-alkaline phosphatase; P-ASAT, plasma-aspartate aminotransferase; P-GT, plasma-glutamyltransferase; TG, triglycerides.
  2. Mean±s.e.m, n=25–28.
Back to article page